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Abstract
Retroviral integrase (IN) catalyzes the integration of viral DNA (vDNA) into host target (tDNA), 
which is an essential step in the lifecycle of all retroviruses1. Prior structural characterization of 
IN-vDNA complexes, or intasomes, from the spumavirus prototype foamy virus (PFV) revealed a 
functional IN tetramer2–5, and it is generally believed that intasomes derived from other retroviral 
genera will employ tetrameric IN6–9. However, the intasomes of orthoretroviruses, which include 
all known pathogenic species, have not been characterized structurally. Using single-particle cryo-
electron microscopy (cryo-EM) and X-ray crystallography, we determine here an unexpected 
octameric IN architecture for the β-retrovirus mouse mammary tumor virus (MMTV) intasome. 
The structure is composed of two core IN dimers, which interact with the vDNA ends and 
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structurally mimic the PFV IN tetramer, and two flanking IN dimers that engage the core structure 
via their IN C-terminal domains (CTDs). Contrary to the belief that tetrameric IN components are 
sufficient to catalyze integration, the flanking IN dimers were necessary for MMTV IN activity. 
The IN octamer solves a conundrum for the β- as well as α-retroviruses by providing critical CTDs 
to the intasome core that cannot be provided in cis due to evolutionarily restrictive catalytic core 
domain (CCD)-CTD linker regions. The octameric architecture of the MMTV intasome provides a 
new paradigm for the structural basis of retroviral DNA integration.
MMTV intasomes were assembled from IN and vDNA components by differential salt 
dialysis, akin to the strategy used for PFV intasomes2. Fractionation of assembly reactions 
by size exclusion chromatography (SEC) revealed a higher-order species with a distinct 
elution profile from those of IN and vDNA (Fig. 1a). To address biological relevance, 
reactions were conducted with supercoiled plasmid tDNA to monitor the concerted 
integration of two vDNA ends10 (Fig. 1b). The SEC-purified complexes catalyzed efficient 
concerted integration activity, which was inhibited by the IN strand transfer inhibitor 
raltegravir (Fig. 1c). The sequencing of concerted integration products excised from agarose 
gels revealed that the majority contained 6 bp target site duplications flanking the integrated 
vDNA ends, which are known to occur during MMTV infection11 (Fig. 1d). To address the 
specificity of complex formation, the invariant CA dinucleotide, which is essential for IN 
catalysis12,13, was mutated to GT in the vDNA substrate. As the mutant vDNA failed to 
support complex formation (data not shown), we conclude that the higher-order species 
identified by SEC are bona fide MMTV intasomes. We note that divalent metal ion was a 
critical cofactor for MMTV intasome formation. Based on prior reports that Ca2+ promoted 
the assembly of active HIV-1 IN-vDNA complexes but was unable to support IN catalysis14, 
it was utilized here for intasome assembly.
To determine the MMTV intasome structure, single-particle cryo-EM data was collected on 
a Titan Krios microscope equipped with a Gatan K2 direct detector. Computational 
processing of the data revealed the most stable structural conformation of the complex, 
which was refined to ~5–6 Å for different regions of the map (Fig. 2a and Extended Data 
Figs. 1 and 2). The MMTV intasome is composed of central core density, as well as flanking 
density regions that are conformationally mobile in comparison to the intasome core 
(Extended Data Fig. 3). Restricting data refinement to the core density region accordingly 
increased the resolution for the central portion of the structure to ~4 Å for the best-resolved 
regions (Extended Data Fig. 2d).
Each IN monomer is composed of an N-terminal domain (NTD), CCD, and CTD (Extended 
Data Fig. 4a), and the map was sufficiently detailed to readily assign these domains to their 
corresponding cryo-EM densities. Given a lack of MMTV IN structures, the different 
protein domains were crystallized as INCCD, INCTD and INNTD-CCD fragments, and these 
structures were refined to 1.7 Å, 1.5 Å and 2.7 Å resolution, respectively (Extended Data 
Fig. 5 and Extended Data Table 1). MMTV DNA was modeled using PFV intasome DNA 
coordinates and by extending the modeled fragment by 3 bp in the region distal from the IN 
active sites to account for the different vDNA lengths. Using rigid body docking, the two 
vDNAs and eight NTDs, CCDs and CTDs were unambiguously positioned into the cryo-EM 
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map (Fig. 2b). Rosetta15–17 was used to refine the X-ray structures and vDNA, and to build a 
subset of interdomain linker regions to best fit the density within the intasome core region 
(Extended Data Fig. 6 and Supplementary Videos 1–5). The resulting model revealed two 
molecules of vDNA and eight MMTV INs arranged as four IN dimers (Fig. 3a). Two 
catalytic IN dimers A and B are positioned in the core region in close contact to the vDNAs, 
whereas supportive IN dimers C and D locate to the flanking density regions, donating their 
CTDs to the core. Flexible linkers connect the IN domains, and the NTD-CCD linker, which 
is contracted in the majority of IN protomers, extends in IN1 and IN3 to donate these NTDs 
in trans to opposing CCDs (Fig. 3a and Extended Data Fig. 6e). Sedimentation velocity 
centrifugation indicated the molecular mass of active MMTV intasomes as 302.1 kDa, 
which is fully consistent with the octameric IN structure (calculated IN8-vDNA2 = 313.6 
kDa; Extended Data Fig. 4b).
The structures of the MMTV and PFV intasomes were compared to ascertain aspects of the 
new structure important for DNA recombination (Fig. 3a). The PFV intasome is composed 
of two IN dimers A and B, with the inner protomers of each dimer (IN1 and IN3; red and 
green in Fig. 3a) adopting extended conformations2. The NTDs and CTDs of the outer IN 
protomers (chartreuse and orange in Fig. 3a) are unseen in PFV intasome density maps. The 
architecture in the core density region of the MMTV intasome is strikingly similar to the 
PFV structure. For example, the positions of the CCDs and NTDs that contact vDNA (red 
IN1 and green IN3 in Fig. 3a) are analogous. The two remaining NTDs in the core region 
stabilize the CCD dimer interface in an arrangement identical to that seen in the INNTD-CCD 
crystal structure (Extended Data Figs. 5d and 6e). Both flanking density regions contain a 
CCD dimer that is also stabilized on each side by NTDs, mimicking the CCD dimer 
arrangements found in the core density region.
The arrangements of the CTDs differ dramatically between the MMTV and PFV structures, 
with MMTV IN residue Arg240 mediating several key contacts. For example, core protomer 
IN1 Arg240 interacts with vDNA while IN2 Arg240 interacts with IN1 Asp233 (Fig. 3b). 
Flanking protomer IN5 Arg240 engages its IN6 neighbor whereas IN6 Arg240 mediates an 
inter-dimeric interaction with core protomer IN1 Asp223, docking the flanking IN dimer to 
the core structure (Fig. 3b). To test the functionality of the flanking IN dimers, 
complementation assays were performed by varying ratios of wild-type (INWT) and mutant 
IN proteins in strand transfer reactions. Similar strategies were used previously to dissect the 
division of labor within multimeric complexes of retroviral IN18–21 as well as the related 
bacteriophage Mu transpososome22.
INR240E, which like INWT purified as a dimer (Extended Data Fig. 7), was defective for 
strand transfer activity (Fig. 4a). To assess the functionality of Arg-240-mediated IN-IN 
interactions, we compared INR240E to INK165E, which carries a change that uniquely 
disrupts IN-vDNA binding2,23. In concordance with its inability to assume the roles of inner 
IN1 and IN3 subunits of the core tetramer, INK165E mildly stimulated the activity of limited 
INWT protein (Fig. 4b), presumably providing a source for other IN subunits within the 
functional complex. INR240E by contrast potently inhibited INWT function, confirming the 
importance of Arg240-mediated protein-protein interactions for MMTV IN activity. Two 
deletion mutant constructs, INCCD-CTD and INCTD, which purified as dimers and monomers, 
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respectively (Extended Data Fig. 7), were additionally analyzed. The reaction composed of 
75% INCCD-CTD supported near INWT activity, indicating that this mutant could function 
when present in up to 6 of 8 octamer positions. This finding strongly supports flanking IN 
dimer functionality, as the absence of the NTD would likewise preclude INCCD-CTD from 
assuming intasome core positions 1 and 3. As the INCTD response curve overlaid that 
predicted for non-functional protein, we moreover conclude that CCD-mediated 
dimerisation is critical for flanking IN CTD function (Fig. 4).
Analysis of IN primary sequences suggests an explanation for the octameric arrangement of 
IN within the MMTV intasome when an IN tetramer suffices for PFV integration. Whereas 
50-residue CCD-CTD linkers afford the positioning of inner PFV IN CTDs for vDNA and 
tDNA engagement2,3, the analogous 8-mer MMTV linker is simply too short to accomplish 
the task (Extended Data Fig. 8a). MMTV has accordingly evolved to employ flanking IN 
dimers to nestle CTDs into the core intasome structure to provide essential CTD function in 
trans for integration. As flanking IN dimer CTDs 6 and 8 structurally mimic the PFV 
domains (Fig. 3a and Extended Data Fig. 8a), we presume these CTDs will engage tDNA 
during MMTV integration. Extending our analysis to other retroviruses indicates that in 
addition to the spumaviruses, IN tetramers could suffice for γ- and ɛ-retroviral intasome 
activity, while an IN octamer will be required to catalyze α-retrovirus in addition to β-
retrovirus integration (Extended Data Fig. 8b). We note that Aihara and colleagues have 
independently determined an octameric IN architecture for the α-retrovirus Rous sarcoma 
virus (RSV) intasome24. Whereas the majority of studies have highlighted a tetramer as the 
IN species that catalyzes concerted HIV-1 integration9,25,26, others have implicated a role for 
octameric IN27,28. Given the intermediary length of lentiviral IN CCD-CTD linker regions 
(Extended Data Fig. 8b), the higher-order nature of IN in active HIV-1 intasomes may need 
to be reevaluated.
PFV IN, which cleaves tDNA phosphodiester bonds separated by 4 bp, preferentially 
integrates into flexible sequences, whereas MMTV and RSV IN, which cleave tDNA with 6 
bp staggers, are relatively unconstrained by tDNA flexibility3,29. Superposition of the 
MMTV and PFV intasome structures revealed that the two sets of catalytic IN active sites 
almost perfectly aligned (Extended Data Fig. 8c). The same practical spacing of IN active 
sites therefore catalyzes PFV and MMTV integration into sharply bent versus relatively non-
deformed tDNA, respectively (Extended Data Fig. 8d). Due to their positions in the 
structure, we note that the flanking IN dimers dramatically expand the potential contact area 
with tDNA, which is likely to have consequences for the docking of α- and β-retroviral 
intasomes to host chromatin.
METHODS
Statistical methods were not used to predetermine sample sizes. Experiments were not 
randomized and the investigators were not blinded to allocation during experiments and 
outcome assessment.
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DNA constructs
Full-length (FL) MMTV IN31 and INCTD (IN212–266 and IN212–319) expression constructs 
provided N-terminal His6 tags followed by human rhinovirus (HRV) 3C protease cleavage 
sites. The INNTD-CCD expression construct was made by introducing a stop codon after the 
TCA that encodes for IN residue Ser212. INK165E and INR240E expression constructs were 
made by PCR-directed mutagenesis. DNA fragments corresponding to IN51–212 (INCCD) and 
IN51–319 (INCCD-CTD) were amplified by PCR and subcloned into expression vector 
pET-20b (Novagen); these proteins harbored cleavable C-terminal His6 tags. The sequences 
of all PCR amplified regions of plasmid DNAs were verified by sequencing.
Protein expression and purification for intasome and IN activity assays
FL INs, INCCD-CTD and INCTD/212–319 were expressed in Escherichia coli strain PC2 (ref. 
32) in LB broth (supplemented with 50 μM ZnCl2 for FL INs) by induction with 0.4 mM 
isopropyl β-D-1-thiogalactopyranoside (IPTG) (1 mM IPTG for INCCD-CTD) at 30 °C (37 °C 
for INCCD-CTD and INCTD) for 4 h. Bacteria pellets were resuspended in 20 mM HEPES, pH 
7.6, 1 M NaCl, 5 mM 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate 
(CHAPS), complete EDTA-free protease inhibitor (Roche). Following sonication for 5 min 
at 50 mA, cell lysates were centrifuged at 45,000 × g for 1 h. The supernatant, supplemented 
with 5 mM imidazole, was filtered through a 0.45 μm filter and purified using a Ni2+-
charged HisTrap 5 mL column (GE Healthcare) equilibrated with 20 mM HEPES, pH 7.6, 1 
M NaCl, 5 mM CHAPS, 15 mM imidazole. Proteins were eluted by a linear gradient of 
imidazole (15–500 mM) containing a step wash at 65 mM imidazole using the ÄKTA 
purifier system (GE Healthcare; for INCCD-CTD, a second step wash was done at 115 mM 
imidazole). IN-containing fractions were diluted 1:5 with 20 mM HEPES, pH 7.6, 5 mM 
CHAPS, 2 mM dithiothreitol (DTT) and immediately loaded on a Heparin HiTrap 5 mL 
column equilibrated with 20 mM HEPES, pH 7.6, 200 mM NaCl, 5 mM CHAPS, 2 mM 
DTT. Proteins were eluted by a linear NaCl gradient from 200 mM to 2 M (INCTD was 
isolated in the column flow through). IN-containing fractions were pooled and cleaved with 
HRV 3C protease (GE Healthcare) overnight at 4 °C to remove the His6 tag. In lieu of 
purification by Heparin HiTrap, INCCD-CTD was dialysed against 20 mM HEPES, pH 7.6, 1 
M NaCl, 5 mM CHAPS, 2 mM DTT, 2 mM EDTA at 4 °C for 2 h, cleaved with HRV 3C 
protease overnight at 4 °C, followed by dialysis against 20 mM HEPES, pH 7.6, 1 M NaCl, 
5 mM CHAPS, 2 mM DTT, 0.5 mM EDTA (SEC1 buffer). Cleaved proteins were purified 
by SEC using a Superdex 200 10/300 column (GE Healthcare) equilibrated with SEC1 
buffer. Purified INs were concentrated by ultracentrifugation using 10-kDa molecular weight 
cutoff Millipore concentrators and dialysed overnight against SEC1 buffer supplemented to 
contain 10% glycerol. Protein concentration was determined by spectrophotometry, and 
aliquots flash-frozen in liquid N2 were stored at −80 °C. Purified INs were analyzed by SEC 
using a Superdex 3.2/300 column equilibrated with SEC1 buffer; protein standards were 
from Bio-Rad.
MMTV intasome assembly
Intasomes were assembled by mixing 128 μM MMTV IN with 38 μM 22 bp preprocessed 
vDNA (5′-CAGGTCGGCCGACTGCGGCA/5′-AATGCCGCAGTCGGCCGACCTG) in 20 
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mM HEPES, pH 7.6, 600 mM NaCl, 2 mM DTT, prior to dialysis for 16 h at 4 °C against 25 
mM Tris-HCl, pH 7.4, 80 mM NaCl, 2 mM DTT, 25 μM ZnCl2, 10 mM CaCl2. The 
resulting milky white precipitate was dissolved by adding NaCl to the final concentration of 
250 mM, followed by incubation on ice for 1 h. Following 10 min centrifugation at 20,000 g 
at 4 °C, soluble intasomes were purified by SEC using Superdex 200 10/300 equilibrated 
with 25 mM Tris-HCl, pH 7.4, 200 mM NaCl, 2 mM DTT, 25 μM ZnCl2, 10 mM CaCl2 
(SEC2 buffer). Intasome-containing fractions, which eluted around 10.5 mL, were 
concentrated by ultracentrifugation using 10-kDa cut off concentrators.
In vitro integration assays
Strand transfer assays were performed as described previously31. Briefly, 1 μM intasome or 
1 μM MMTV IN plus 0.5 μM vDNA were mixed with 300 ng pGEM-3 tDNA in 40 μL of 20 
mM HEPES, pH 7.4, 60 mM NaCl, 5 mM MgCl2, 4 μM ZnSO4, 10 mM DTT. Reactions 
incubated for 1 h at 37 °C were terminated by adding 25 mM EDTA–0.5 % SDS. DNA 
products deproteinized by digestion with proteinase K and precipitated with ethanol were 
analyzed by electrophoresis through 1.5% agarose gels and visualized by staining with 
ethidium bromide. Raltegravir, which was used at the final concentration of 100 μM, was 
obtained from Selleck Chemicals. Proteins were premixed on ice prior to addition to 
reactions for biochemical complementation assays. Concerted integration products were 
measured by band intensity quantification relative to INWT product formation, which was set 
to 100% using Molecular Imager® Gel Doc TM XR+ System with Image Lab software 
(BioRad); the background across 8 gel images corresponded to 1.26% ± 0.47% of INWT 
function.
Concerted integration reaction products were cloned and sequenced essentially as previously 
described32. Briefly, DNA excised from agarose gels was repaired using Phi29 DNA 
polymerase (New England Biolabs) and ligated to a PCR-amplified kanamycin resistance 
cassette. Plasmids recovered following transformation of ligation mixtures into E. coli were 
sequenced using primers that annealed to the ends of the cassette DNA.
Analytical ultracentrifugation
Sedimentation velocity analysis was performed at 20 °C in a Beckman Optima XL-I 
analytical ultracentrifuge using an An60Ti rotor and standard 2-channel epon centerpieces 
(Beckman-Coulter). Samples were prepared in 20 mM phosphate buffer, pH 7.5, 150 mM 
NaCl at two loading concentrations, A280 values of 0.3 and 0.9 for MMTV IN and the 
intasome, and A280 values of 0.18 and 0.53 for vDNA, to exclude potential mass action 
oligomerization. IN and vDNA were spun simultaneously at 35,000 rpm for 22 h while the 
intasome was spun at 27,000 rpm for 12 h; the different rotor speeds were based on the 
predicted masses of the different macromolecules.
Data were analyzed using UltraScan-III version 2.2, release 2000 (ref. 33). Hydrodynamic 
corrections for buffer density and viscosity were estimated with UltraScan to be 1.041 g/mL 
and 1.101 cP, respectively. The partial specific volume of IN (0.728 mL/g) was estimated by 
UltraScan from its protein sequence using a method analogous to the methods outlined in 
Laue et al.34. Sedimentation velocity data were analyzed as described35. Optimization was 
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performed by two-dimensional spectral analysis (2DSA)36 with simultaneous removal of 
time-invariant and radially-invariant noise contributions37. 2DSA solutions, which are 
subjected to parsimonious regularization by genetic algorithm analysis38, were further 
refined using Monte Carlo analysis to determine confidence limits for the determined 
parameters39. Calculations were performed on the Lonestar cluster at the Texas Advanced 
Computing Center at the University of Texas at Austin.
Protein expression and X-ray crystallography
MMTV INCCD, INNTD-CCD and INCTD fragments spanning MMTV IN residues 51–212, 1–
212 and 212–266, respectively, were expressed in BL21(DE3)-CodonPlus cells (Stratagene) 
in LB medium (supplemented with 50 μM ZnCl2 for INNTD-CCD) by induction with 0.01% 
(w/v) IPTG. Bacteria were lysed by sonication in 0.5 M NaCl, 50 mM Tris-HCl, pH 7.4 and 
the proteins were isolated by absorption to Ni-nitrilotriacetic acid agarose (Qiagen). 
Following digestion with HRV 3C protease to release His6 tags, the proteins were further 
purified by ion exchange and size exclusion chromatography.
Crystals were grown by vapor diffusion in hanging drops by mixing 1 μL protein (6–10 
mg/mL in 200 mM NaCl, 2 mM DTT, 25 mM Tris-HCl, pH 7.5) and 1 μL reservoir solution, 
which contained 12.5% PEG-3350, 0.15 M ammonium citrate, pH 6.5 (INCCD), 19% 
PEG-3350, 0.2 M MgCl2, 5% (v/w) 1-butyl-3-methylimidazolium dicyanamide 
(INNTD-CCD), or 19% isopropanol, 50 mM ammonium acetate, 0.1 M HEPES-NaOH, pH 
7.5 (INCTD). Crystals, cryoprotected with 25% glycerol (INCCD, INNTD-CCD) or 30% 
PEG-400 (INCTD), were frozen by immersion in liquid N2. Diffraction data for the INCCD 
was collected using a charged coupled device detector at beamline BM14 (European 
Synchrotron Radiation Facility [ESRF]) whereas INCTD and INNTD-CCD crystals were 
analyzed at beamline I03 (Diamond Light Source) equipped with a PILATUS direct detector. 
The data integrated with XDS40 were scaled with Aimless41. The structures, which were 
each derived from a single crystal, were solved by molecular replacement in Phaser42 using 
search models generated from PDB entries 1ASV (CCD)43, 3F9K (NTD)10 and 1EX4 
(CTD)44. The models were rebuilt using ARP/wARP45 and/or manually in Coot46 and 
refined in Phenix47 and/or Refmac48. Pseudo-merohedral twin law (-h,-k,l) was accounted 
for during refinement of the INNTD-CCD structure. Final models, validated with 
MolProbity49, had at least 96.9% of residues in the favored regions and none in the 
disallowed regions of the Ramachandran plot. Detailed X-ray data collection and refinement 
statistics are given in Extended Data Table 1.
Cryo-EM data acquisition
Sample containing MMTV intasomes in SEC2 buffer supplemented to contain 0.05% NP-40 
was applied onto freshly plasma treated (6s, Gatan Solarus plasma cleaner) holey carbon C-
flat grids (CF-1.2/1.3–4C, Protochips, Inc.), adsorbed for 30 sec and then plunged into liquid 
ethane using a manual cryo-plunger in an ambient environment of 4 °C.
Data were acquired over three separate sessions using Leginon software50 installed on an 
FEI Titan Krios electron microscope operating at 300 kV, with a dose of 40 e-/Å2 at the rate 
of ~6.9 e-/pix/sec and an estimated underfocus ranging from 1–4 μm (centered at 2.6 ± 0.6 
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μm). The dose was fractionated over 50 raw frames collected over 10-sec exposure time (200 
ms per frame) on the Gatan K2 Summit direct detection device, with each frame receiving a 
dose of ~6.5 e-/pixel/sec. 2714 movies were collected and recorded at a nominal 
magnification of 22,500, corresponding to a pixel size of 1.31 Å at the specimen level. The 
individual frames were gain corrected, aligned and summed using a GPU-enabled whole 
frame alignment program as previously described51,52, and exposure filtered53 according to 
the 6.9 e-/pix/sec dose rate. See Extended Data Table 2 for additional details on cryo-EM 
data collection.
Cryo-EM image analysis
Pre-processing operations prior to the refinement of the final models were performed using 
the Appion package54 and are conceptually identical to those previously described52. 
Briefly, single intasome particles (244,315) were selected from the aligned and summed 
micrographs, from which 147,850 were used to create an initial raw particle stack after 
removing regions of the micrographs containing carbon and large areas of aggregation. 2D 
alignments and classifications were performed using the CL2D55 and Relion56 algorithms 
(Extended Data Fig. 1c), and an initial model was generated directly from the class averages 
using OptiMod57 (Extended Data Fig. 1d). Following iterative rounds of 2D alignment and 
classification, 77,365 particles remained for 3D refinement and classification. 3D 
refinements and classifications were initially performed within Relion56, after which the 
parameters were converted for use in Frealign58. The final map was refined in Frealign.
Several conformational states of the intasome were observed following 3D classification in 
both Relion and Frealign59. Whereas one of the resulting maps yielded the stable intasome 
structure from 41,475 particles (Fig. 2a, Extended Data Fig. 2c and Extended Data Table 2), 
all other maps (one of which is displayed in Extended Data Fig 3b) displayed mobility in the 
flanking regions, which did not resolve by further classifying the data. To improve the 
resolution of the core region, we ran Relion and recovered four models in the classification. 
For each of the resulting maps, the flanking regions were segmented and treated with a soft-
edged mask that adopted the shape of the remaining density. Subsequently, for each raw 
particle, the flanking region from the respective conformational state to which that particle 
belonged was computationally subtracted from the raw particle image. The contrast transfer 
function was included in the computational subtraction process. In this manner, datasets 
lacking the majority of the flanking INs were created. Refinement of the core intasome 
dataset was then conducted using the likelihood-based approach in Frealign59, effectively a 
focused classification of the core region. The best class was resolved to ~4 Å resolution in 
the most homogeneous regions using 30,307 particles (Extended Data Fig. 2d and Extended 
Data Table 2). Although slight ghost images remained for the flanking regions within certain 
particles, they did not dramatically affect the refinement; the use of a tighter mask facilitated 
the recovery of higher resolution information.
Assembly of the atomic model
Models of the core intasome and the full octamer structures were built and refined in a 
stepwise manner using Rosetta15 starting with rigid-body fitted X-ray structures of 
individual domains as input. Rosetta protocols were used for all parts of the modeling60. To 
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optimally fit X-ray models into the EM density, we first independently refined each 
individual domain (NTD, CCD and CTD) using multiple input starting seeds. CCD1 and 
CCD2 were each seeded with 6 starting X-ray models: independent CCD monomers from 
chains A-D of the INCCD structure and monomers A-B of the CCD portions of the 
INNTD-CCD structures. CTDs 1, 2, 5 and 6 were seeded with subunits A and B of the INCTD 
X-ray model. Likewise, for NTD1 and NTD3, the two different NTDs of the INNTD-CCD X-
ray structure were used as input seeds. All models were refined against the core intasome 
structure resolved to ~4–5 Å resolution (Extended Data Fig. 2d). At least 2000 models were 
generated from each and the lowest energy model was selected for moving forward. 
Modeling quality was assessed by energy scores, structural similarity of the top scoring 
models, and visual inspection (Extended Data Fig. 6a). We next proceeded to independently 
model IN1, IN2, IN5 and IN6, thereby filling in the linker regions between individual 
domains using 7-mers from the PDB15. This enabled de novo modeling for linker residues 
45–54 between NTD1-CCD1 and residues 211–213 between CCD1-CTD1 and CCD2-CTD2 
(some residues, as well as outlier linker regions, were not modeled due to disorder; Extended 
Data Fig. 6b and 6c); modeling was facilitated by the presence of ‘bumps’ within the density 
that corresponded to bulky amino acid side chains, in particular within NTD1-CCD1, which 
is located in the best resolved region of the structure (Extended Data Fig. 2d). IN1 and IN2 
were each seeded with combinations of the best models arising from refinement of 
individual domains and were subsequently refined against the core intasome density map. 
2000 models were again generated for each, and the best were selected to move forward. 
This set of procedures produced FL models for IN1 and IN2 and models for CTD5 and CTD6 
fitted to the EM protein density. MMTV DNA was modeled based on the X-ray structure of 
the PFV intasome (PDB 3L2Q). This model was rigid-body docked into the EM density and 
then relaxed with Rosetta. The complete intasome model was iteratively relaxed with 
Rosetta and then adjusted manually using Coot46. Several iterative rounds of refinement and 
inspection were performed using MolProbity49 at the end of each round until a consensus 
model was obtained (Extended Data Fig. 6c,d and Extended Data Table 2).
IN linker regions
Linker lengths for Extended Data Figure 8b were assessed by aligning published30 or in-
house generated IN sequence alignments against alignments based on known domain 
structures2 (Extended Data Fig. 4a). The following sequences were included: γ-retroviruses, 
Moloney murine leukemia virus (Genbank accession number J02255.1), 
reticuloendotheliosis virus strain A (DQ237900.1), feline leukemia virus (NC_001940.1); ɛ-
retroviruses, walleye dermal sarcoma virus (NC_001867.1), walleye epidermal hyperplasia 
virus types 1 and 2 (AF133051.1 and AF133051.2, respectively); spumaviruses, PFV 
(U21247.1), macaque simian foamy virus (NC_010819.1), spider monkey foamy virus 
(EU010385.1); lentiviruses, HIV-1 strain NL4–3 (U26942.1), HIV-2 strain ROD 
(X05291.1), simian immunodeficiency virus strain agm.tan-1 (U58991.1), equine infectious 
anemia virus (M16575.1), feline immunodeficiency virus (M25381.1), caprine arthritis 
encephalitis virus (M33677.1), bovine immunodeficiency virus (NC_001413.1); δ-
retroviruses, bovine leukemia virus (K02120.1), human T-cell lymphotropic virus types 1 
and 2 (NC_001436.1 and NC_001488.1, respectively); β-retroviruses, MMTV 
(NC_001503.1), Mason Pfizer monkey virus (NC_001550.1), Jaagsiekte sheep retrovirus 
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(NC_001494.1); α-retroviruses, RSV (J02342.1), lymphoproliferative disease virus 
(KC802224.1).
Extended Data
Extended Data Figure 1. Cryo-EM data and refinement
a, Representative cryo-electron micrograph of MMTV intasomes, taken at 2.7 μm 
underfocus. b, Same as in panel a, marked to show selected particles. c, 2D class averages 
calculated using Relion56. d, Initial model from the class averages calculated using 
OptiMod57. e, Refined reconstruction from the full dataset, with an Euler angle distribution 
plot showing the relative orientations of the particles.
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Extended Data Figure 2. Cryo-EM resolution analysis of reconstructed intasome maps
a, Fourier shell correlation (FSC) curve corresponding to the refined map generated from the 
full intasome dataset. b, FSC curve corresponding to the refined map generated from the 
core intasome dataset with the NTDs, CCDs and interdomain linker regions of the flanking 
IN dimers computationally subtracted. Average global resolutions in panels a and b are 
indicated. c, Refined map generated from the full dataset (left) displayed side-by-side with 
the same map colored for local resolution (right). d, Refined map generated from the core 
intasome dataset (left) displayed side-by-side with the same map colored for local resolution 
Ballandras-Colas et al. Page 11
Nature. Author manuscript; available in PMC 2016 August 18.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
(right) using the coloring scheme in panel c. e, Rotational snapshots of segmented density of 
CCD1 with the fit of the refined model (see Extended Data Fig. 6) highlighting structural 
features evident at ~4–5 Å resolution. Partial separation of β-strands, which is typically 
evident at or beyond 4.5 Å resolution, is apparent.
Extended Data Figure 3. Structural heterogeneity of the MMTV intasome
a, Stable structural conformation of the MMTV intasome after 3D classification of the data. 
Slices from the density map are displayed below. b, One of several conformations of MMTV 
intasome refinement after 3D classification of the data. Slices from the density map are 
displayed below. Multiple fuzzy regions in the flanking INs are apparent in b, which are 
indicative of remaining heterogeneity within the data and/or continuous structural mobility 
of the region. c, Overlay of the two reconstructed maps, highlighting the extent of mobility 
within the flanking regions (brackets).
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Extended Data Figure 4. MMTV IN domains and intasome sedimentation coefficient distribution
a, Primary IN sequence alignment with boxes denoting canonical IN structural domains. The 
N-terminal extension domain (NED) occurs in spuma-, γ- and ɛ-retroviral IN proteins. 
Identical residues between MMTV, RSV, HIV-1 and PFV INs are highlighted by red 
background; residues that are minimally conserved in three of the sequences are in red. PFV 
IN secondary structure elements are from PDB code 3L2Q; MMTV elements are from the 
INNTD-CCD and INCTD crystal structures described here (PDB codes 5CZ2 and 5D7U, 
respectively). α, β, η, TT and TTT represent α helix, β strand, 310 helix, α-turn and β-turn, 
respectively. Figure generated with ESPript 3.0 (ref. 61). b, Monte Carlo analysis of 
sedimentation velocity data for the higher loading concentrations of vDNA (green), MMTV 
IN (blue) and intasome (red). A clear shift to a discrete species at 10.5 s is observed for the 
intasome, with minor IN and vDNA populations evident. Different centrifugation parameters 
for IN and vDNA versus intasomes (see Methods) likely attributed to the minor variations in 
sedimentation coefficient between major and minor IN and vDNA species. Measured 
sedimentation coefficients and calculated molar masses compared to theoretical molar 
masses are shown beneath the graph.
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Extended Data Figure 5. MMTV IN domain crystal structures
a, Stereo view of the final 2Fo-Fc density map of the INCCD crystal structure with blue mesh 
contoured at 1σ. Amino acid side chains are readily evident at the 1.7 Å resolution. b, Stereo 
view of the final 2Fo-Fc density map of the 2.7 Å resolution INNTD-CCD crystal structure 
with blue mesh contoured at 1σ. The map is centered on the DDE catalytic triad (red sticks); 
green spheres, Mg2+ ions. c, Cartoon representation of the INCCD monomer (one of 4 in the 
crystallographic asymmetric unit) colored in gold. Active site residues are shown as red 
sticks. d, Cartoon representation of the INNTD-CCD dimer structure (one of 3 in the 
asymmetric unit). The NTD and CCD are colored green and gold, respectively. Red sticks, 
active site residues; grey and green spheres, Zn2+ and Mg2+ ions, respectively. e, Stereo view 
of the final 2Fo-Fc density map of the 1.5 Å resolution INCTD crystal structure, shown as a 
green mesh contoured at 1σ. f, Cartoon representation of one of the two CTD monomers 
present in the asymmetric unit.
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Extended Data Figure 6. Molecular modeling of cryo-EM density
a, Stereo views showing comparisons between the starting X-ray domain models and refined 
cryo-EM domain models for IN1 highlight relatively minor structural perturbations that are 
evident only in the most flexible regions of the intasome. b, Linker region snapshots. Atomic 
models were built de novo from the cryo-EM density for the indicated linkers in the top two 
panels (residues 45–54 connecting NTD1 and CCD1 and CCD-CTD residues 211–213). 
Linkers NTD2-CCD2, CCD5-CTD5 and CCD6-CTD6 were not modeled, but are shown as 
cryo-EM density (red) in the lower panels. c, Stereo view of the cryo-EM model for the 
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MMTV intasome core region (Extended Data Fig. 2d), generated using Rosetta15–17. All 
domains were refined starting with the X-ray crystal structures (Extended Data Fig. 5). 
Specific linker regions were built de novo (continuous red lines) from the cryo-EM density, 
whereas lower resolution linker regions (red dotted lines) were omitted from the model. d, 
FSC curve between the refined cryo-EM core intasome model and map, showing an average 
resolution of 4.8 Å. e, Comparison of two NTD-CCD conformations in the intasome 
highlights the NTD-CCD linker, which assumes a retracted state in the outer IN2 and IN4 
monomers of core intasome dimers A and B, respectively, as well as in flanking IN dimers C 
and D (left). The linker extends in core IN molecules IN1 and IN3, which interact with the 
vDNA (right).
Extended Data Figure 7. Gel filtration profiles of INWT and IN mutant proteins
Migration positions of mass standards in kDa as well as theoretical protein monomer (M) 
and dimer (D) positions are indicated.
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Extended Data Figure 8. Comparisons of PFV and MMTV intasome structures
a, Cartoon representations of the inner IN3 green subunits of the MMTV and PFV intasomes 
(Fig. 3a; vDNA strands are in grey). CCD-CTD linker regions are highlighted in orange, and 
dashed lines circle analogously positioned CTDs. Of note, this CTD in the MMTV structure 
is colored differently because it originates from a separate IN molecule (IN8 from flanking 
dimer D). b, Lengths of NTD-CCD and CCD-CTD interdomain linker regions across 
retroviral IN proteins; ‘+’ indicates the presence of an NED. The multimeric state of IN in 
known intasome structures is indicated by bold type. c, The PFV intasome with bound tDNA 
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(PDB code 3OS2; orange) was superimposed with the MMTV intasome (blue). The distance 
between overlaid active sites is in each case ~26 Å. d, 90° rotation of superimposed 
structures, with proteins omitted for clarity. Canonical B-form tDNA (magenta) was 
superimposed with PFV intasome tDNA. The positions of phosphodiester bonds staggered 
by 4 bp in the PFV crystal structure or by 6 bp in the modeled tDNA are indicated by 
spheres.
Extended Data Table 1
X-ray crystallography data collection and refinement statistics.
Construct CCD NTD-CCD CTD
Data collection
Space group P1 P1211 C2221
Cell dimensions
 a, b, c (Å) 51.89, 53.71,69.65 54.37, 83.15, 141.14 35.99,42.28, 139.09
 a, b, g (°) 69.69, 82.08, 63.97 90,90.19,90 90, 90, 90
Resolution (Å)* 46.6 – 1.70(1.73–1.70) 70.6 – 2.72 (2.79 – 2.72) 40.4 – 1.50(1.53–1.50)
Rmerqe 0.060 (0.57) 0.08 (0.534) 0.043 (0.585)
llsl 21.0(2.0) 9.5(2.0) 29.2 (3.8)
Completeness (%) 99.1 (95.6) 99.3 (99.0) 99.8 (99.9)
Redundancy 5.2 (2.8) 3.2(3.1) 12.2 (8.9)
Refinement
Resolution (Å) 32.8 – 1.70 70.6 – 2.72 40.4 – 1.50
No. reflections used 69,075 32,115 17,448
Rwork/Rfree 0.189/0.222 0.245/0.266 0.165/0.202
No. atoms
 Protein 4,983 9,110 890
 Ligand/ion 0 12 8
 Water 437 0 69
B-factors
 Protein 26.0 70.9 28.5
 Ligand/ion – 45.6 46.4
 Water 33.5 – 46.9
R.m.s deviations
 Bond lengths (Å) 0.007 0.010 0.005
 Bond angles (°) 0.954 1.281 0.911
*
Data for the highest resolution shells are given in parenthesis.
Extended Data Table 2
Cryo-EM data statistics.
Construct core MMTV intasome full MMTV intasome
EM data collection/processing
Microscope Titan Krios Titan Krios
Voltage 300 300
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Construct core MMTV intasome full MMTV intasome
Camera Gatan K2 Summit Gatan K2 Summit
Defocus range (μm) 1.0–4.0 1.0–4.0
Defocus mean ± std (μm) 2.6 ± 0.6 2.6 ± 0.6
Exposure time (s) 10 10
Dose rate (e-/pixel/s) 6.9 6.9
Total dose (e-/Å2) 40 40
Pixel size (Å) 1.31 1.31
Number of micrographs 2,714 2,714
Number of particles (processed) 147,850 147,850
Number of particles (refined) 77,365 77,365
Number of particles (in final map) 30,307 41,475
Symmetry C2 C2
Resolution (global) (Å)* 4.8 6.0
Resolution range (local) (Å) 4–5 5–6
Map sharpening B-factor (Å2) −300 −460
Model refinement
Space group P1 –
Cell dimensions
 a = b = c (Å) 151.2 –
 a=b = g (°) 90 –
Number of atoms (modeled) 11,462 –
Validation
MolProbity score 1.46 (96th percentile) –
Clashscore, all atoms 2.27 (99th percentile) –
Protein
 Ramachandran favored (%) 1,115(92.76) –
  allowed (%) 87 (7.24) –
  Disallowed (%) 0(0) –
 Good rotamers (%) 1,035(99.71) –
 Cβ deviations >0.25Å (%) 0(0) –
 Cis Prolines (%) 8/88(9.09) –
 Bad bonds (%) 2/10,140(0.02) –
 Bad angles (%) 3/13,810(0.02) –
DNA
 Bad bonds (%) 0/1,834(0) –
 Bad angles (%) 1/2,822 (0.04) –
r.m.s. deviations
 Bond lengths (Å) 0.012 –
 Bond angles (°) 1.334 –
*
Resolution assessment based on frequency-limited refinement using the 0.143-threshold for resolution analysis.
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Refer to Web version on PubMed Central for supplementary material.
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Figure 1. MMTV intasome (Int) characterization
a, Purification by SEC. Elution positions of mass standards in kDa are indicated. b, 
Integration assay schematic. Int or IN plus vDNA was reacted with supercoiled tDNA, 
which can yield half site (h.s.) or concerted integration (c.i.) products. c, Ethidium bromide-
stained agarose gel. Lane 1–3 reactions were initiated with IN; vDNA was omitted from lane 
1. Raltegravir (RAL) was included as indicated. Lanes 4 and 5, Int reactions. Migrations 
positions of h.s. products that co-migrate with open circular (o.c.) tDNA, c.i. products, 
supercoiled (s.c.) tDNA and mass standards in kb are indicated. For gel source data, see 
Supplementary Figure 1. d, Sequenced Int-mediated concerted integration products (n=35).
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Figure 2. Cryo-EM structure of the MMTV intasome
a, top view (upper) of the cryo-EM map; the lower view is rotated 90°. Core density and 
flanking density regions are indicated. b, Individual domain crystal structures (NTD, green; 
CCD, orange; CTD, purple) and vDNA (blue) model fitted by rigid body docking. Rulers 
demarcate 20 Å.
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Figure 3. Comparison of MMTV and PFV intasome structures
a, MMTV (left) and PFV (right) intasomes color coded to highlight IN dimers and 
constituent protomers. Core dimers A and B are red-orange and green-chartreuse, 
respectively, while MMTV flanking IN dimers C and D are blue-sky blue and purple-light 
pink, respectively. Colored circles highlight similarly positioned CTDs between structures. 
b, Close-up views of Arg240-mediated protein (left) and vDNA (right; G6 of plus-strand) 
interactions. For simplicity, only one set of asymmetric interactions is shown. The 
interaction of IN5 with residues 258–261 of IN6 varied during model refinement, with the 
indicated interaction (as well as other atomic distances) observed in the final refined model. 
Colors are conserved between panels a and b.
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Figure 4. MMTV intasome functionality
a, Representative agarose gels. The reactions in lanes 1–4 contained 1,0, 0.75, 0.5, 0.25 μM 
INWT, respectively; IN was omitted from the reaction in lane 5. Subsequent 5-reaction sets 
contained the same INWT concentrations with 0, 0.25, 0.5, 0.75, 1.0 μM of the indicated 
mutant protein, for a total concentration of 1 μM IN in lanes 6–25. Lanes 1–5 versus lanes 
6–15 and 16–25 were from separate agarose gels (see Supplementary Fig. 1 for gel source 
data); other labeling as in Fig. 1. b, Dashed lines indicate theoretical activities (graphed as 
percent INWT activity) for mixtures that contain a mutant protein that supports full INWT 
function when present in 6 of 8 octamer positions (blue dashed line), 4 of 8 positions (green 
dashes), 2 positions (purple dashes) or is unable to complement INWT function (pink 
dashes). Actual activities are from 4 technical replicates (average ± s.e.m.; see 
Supplementary Table 1 for source data). The non-linear response of INWT (grey line with 
red diamonds) likely reflects concentration-dependent cooperative multimerization of IN 
with vDNA30. The INWT alone and INWT + INCTD values were not significantly different (P 
>0.1; two-tailed t-test). *, P <0.05; **, P <0.01.
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